ELIC · Elicera Therapeutics AB · Insider Trading
Transactions in Elicera Therapeutics AB securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.
Director and related-person transactions
Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.
| Transaction date | Person | Transaction | Instrument | Volume | Price | Status |
|---|---|---|---|---|---|---|
| 2026-01-22 | Magnus Essand Member of the Board of Directors | Loan received | Elicera Therapeutics AB Share · SE0015382080 | 280000 Quantity | 0 SEK | Current |
| 2025-05-27 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Disposal | Elicera Therapeutics AB Share · SE0015382080 | 20000 Quantity | 6.59 SEK | Current |
| 2025-05-26 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Disposal | Elicera Therapeutics AB Share · SE0015382080 | 25000 Quantity | 7.06 SEK | Current |
| 2025-05-23 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Disposal | Elicera Therapeutics AB Share · SE0015382080 | 102500 Quantity | 6.51 SEK | Current |
| 2025-05-22 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Disposal | Elicera Therapeutics AB Share · SE0015382080 | 237500 Quantity | 6.3 SEK | Current |
| 2025-03-11 | Margareth Jorvid Member of the Board of Directors | Subscription | Elicera Therapeutics AB Interim share · SE0015382080 | 21700 Quantity | 1.85 SEK | Current |
| 2025-03-11 | Magnus Essand Member of the Board of Directors | Subscription | Elicera Therapeutics AB Interim share · SE0015382080 | 43211 Quantity | 1.85 SEK | Current |
| 2025-03-11 | Agneta Edberg Chairman of the Board of Directors | Subscription | Elicera Therapeutics AB Interim share · SE0015382080 | 27027 Quantity | 1.85 SEK | Current |
| 2025-03-11 | Christina Herder Member of the Board of Directors | Subscription | Elicera Therapeutics Interim share · SE0024173025 | 21700 Quantity | 1.85 SEK | Current |
| 2025-03-11 | Di Yu Deputy Member of the Board of Directors | Subscription | Elicera Therapeutics AB Interim share · SE0024173025 | 50000 Quantity | 1.85 SEK | Current |
| 2025-03-11 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Subscription | Elicera Therapeutics AB Interim share · SE0015382080 | 151900 Quantity | 1.85 SEK | Current |
| 2025-03-11 | Rolf Ingvar Lennart Karlsson Chief Financial Officer (CFO) | Subscription | Elicera Therapeutics AB Interim share · SE0015382080 | 51600 Quantity | 1.85 SEK | Current |
| 2025-03-10 | Rolf Ingvar Lennart Karlsson Chief Financial Officer (CFO) | Acquisition | Elicera Therapeutics AB TO2 Option · SE0021626314 | 18000 Quantity | 0.5 SEK | Current |
| 2024-05-14 | Magnus Essand Member of the Board of Directors | Loan granted | Elicera Therapeutics AB Share · SE0015382080 | 280000 Quantity | 0.94 SEK | Current |
| 2024-04-25 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Acquisition | Elicera Therapeutics AB Aktie Share · SE0015382080 | 50000 Quantity | 1 SEK | Current |
| 2024-03-20 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Disposal | Elicera Therapeutics AB Share · SE0015382080 | 2687000 Quantity | 1.28 SEK | Current |
| 2024-03-20 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Acquisition | Elicera Therapeutics AB Share · SE0015382080 | 2687000 Quantity | 1.28 SEK | Current |
| 2024-03-08 | Agneta Edberg Chairman of the Board of Directors | Subscription | Elicera Therapeutics AB BTU BTU · SE0021626306 | 4518 Quantity | 16.2 SEK | Current |
| 2024-03-08 | Margareth Jorvid Member of the Board of Directors | Subscription | EliceraTherapeutics AB BTU BTU · SE0021626306 | 3100 Quantity | 16.2 SEK | Current |
| 2024-03-08 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Subscription | Elicera Therapeutics AB BTU BTU · SE0021626306 | 21700 Quantity | 16.2 SEK | Current |
| 2024-03-08 | Christina Herder Member of the Board of Directors | Subscription | Elicera Therapeutics AB BTU BTU · SE0021626306 | 3100 Quantity | 16.2 SEK | Current |
| 2024-03-08 | Jan Zetterberg Member of the Board of Directors | Subscription | Elicera Therapeutics AB BTU BTU · SE0021626306 | 10000 Quantity | 16.2 SEK | Current |
| 2024-03-08 | Jan Zetterberg Member of the Board of Directors | Subscription | Elicera Therapeutics AB BTU BTU · SE0021626306 | 4300 Quantity | 16.2 SEK | Current |
| 2024-03-04 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Acquisition | Elicera Therapeutics AB UR Subscription right/Unit right · SE0021626298 | 31000 Quantity | 0.0051 SEK | Current |
| 2024-03-04 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Disposal | Elicera Therapeutics AB UR Subscription right/Unit right · SE0021626298 | 1687000 Quantity | 0.00159 SEK | Current |
| 2024-03-01 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Disposal | Elicera Therapeutics AB UR Subscription right/Unit right · SE0021626298 | 500000 Quantity | 0.0024 SEK | Current |
| 2024-02-26 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Acquisition | Elicera Therapeutics AB UR Subscription right/Unit right · SE0021626298 | 64500 Quantity | 0.0183 SEK | Current |
| 2024-03-08 | Magnus Essand Chairman of the Board of Directors | Subscription | Elicera Therapeutics AB BTU BTU · SE0015382080 | 6173 Quantity | 16.2 SEK | Current |
| 2024-03-08 | Di Yu Deputy Member of the Board of Directors | Subscription | Elicera Therapeutics AB BTU BTU · SE0021626306 | 12345 Quantity | 16.2 SEK | Current |
| 2024-03-08 | Rolf Ingvar Lennart Karlsson Chief Financial Officer (CFO) | Subscription | Elicera Therapeutics AB BTU BTU · SE0021626306 | 4800 Quantity | 16.2 SEK | Current |
| 2021-07-07 | Magnus Essand Chairman of the Board of Directors | Return of loan increase | Elicera Therapeutics A Share · SE0015382080 | 2583333 Quantity | 0 SEK | Current |
| 2021-07-08 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Return of loan increase | Elicera Therapeutics A Share · SE0015382080 | 2583333 Quantity | 0 SEK | Current |
| 2021-07-07 | Di Yu Deputy Member of the Board of Directors | Return of loan increase | Elicera Therapeutics A Share · SE0015382080 | 2583334 Quantity | 0 SEK | Current |
| 2021-07-05 | Magnus Essand Member of the Board of Directors | Acquisition | Elicera Therapeutics A Share · SE0015382080 | 12100 Quantity | 4.3 SEK | Current |
| 2021-07-05 | Agneta Edberg Chairman of the Board of Directors | Acquisition | Elicera Therapeutics A Share · SE0015382080 | 12791 Quantity | 4.3 SEK | Current |
| 2021-07-05 | Karin helene Hoogendoorn Other member of the company's administrative, management or supervisory body | Acquisition | Elicera Therapeutics AB Share · SE0015382080 | 23000 Quantity | 4.3 SEK | Current |
| 2021-07-05 | Jan Zetterberg Member of the Board of Directors | Acquisition | Elicera Therapeutics AB Share · SE0015382080 | 14000 Quantity | 4.3 SEK | Current |
| 2021-07-05 | Jamal El Mosleh Chief Executive Officer (CEO)/Managing Directory | Acquisition | Elicera Therapeutics A Share · SE0015382080 | 23000 Quantity | 4.3 SEK | Current |
| 2021-07-05 | Di Yu Deputy Member of the Board of Directors | Acquisition | Elicera Therapeutics A Share · SE0015382080 | 12100 Quantity | 4.3 SEK | Current |
| 2021-07-05 | Margareth Jorvid Member of the Board of Directors | Acquisition | Elicera Therapeutics AB Share · SE0015382080 | 12100 Quantity | 4.3 SEK | Current |
| 2021-07-05 | Rolf Ingvar Lennart Karlsson Chief Financial Officer (CFO) | Acquisition | Elicera Therapeutics A Share · SE0015382080 | 23500 Quantity | 4.3 SEK | Current |
| 2021-06-06 | Karin helene Hoogendoorn Other senior executive | Allotment | Elicera Therapeutics TO1 Warrant · SE0015988233 | 12500 Quantity | 0 SEK | Current |
| 2021-06-06 | Karin helene Hoogendoorn Other senior executive | Allotment | Elicera Therapeutics A Share · SE0015382080 | 12500 Quantity | 8 SEK | Current |
| 2021-06-11 | Christina Herder Member of the Board of Directors | Allotment | Elicera Therapeutics A Share · SE0015382080 | 6500 Quantity | 8 SEK | Current |
| 2021-06-11 | Christina Herder Member of the Board of Directors | Allotment | Elicera Therapeutics TO1 Option · SE0015988233 | 6500 Quantity | 0 SEK | Current |
| 2021-06-11 | Di Yu Deputy Member of the Board of Directors | Allotment | Elicera Therapeutics A Share · SE0015382080 | 7500 Quantity | 8 SEK | Current |
| 2021-06-11 | Di Yu Deputy Member of the Board of Directors | Allotment | Elicera Therapeutics TO1 Option · SE0015988233 | 7500 Quantity | 0 SEK | Current |
| 2021-06-11 | Magnus Essand Member of the Board of Directors | Allotment | Elicera Therapeutics A Share · SE0015382080 | 9375 Quantity | 8 SEK | Current |
| 2021-06-11 | Magnus Essand Member of the Board of Directors | Allotment | Elicera Therapeutics TO1 Option · SE0015988233 | 9375 Quantity | 0 SEK | Current |
| 2021-06-10 | Magnus Essand Member of the Board of Directors | Loan granted | Elicera Therapeutics A Share · SE0015382080 | 2583333 Quantity | 0 SEK | Current |
3748 publication days captured; dates between 2016-07-03 and 2026-10-08 may contain gaps. Checked 2026-10-08 22:11 UTC.